San Mateo, CA, United States of America

Peter B Kirk

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Peter B Kirk

Introduction

Peter B Kirk is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of biotechnology, particularly in the development of polypeptide libraries. With a total of 4 patents, his work has advanced the understanding of fibronectin-type binding peptides.

Latest Patents

Kirk's latest patents include the creation of universal fibronectin type III binding-domain libraries. These libraries consist of Fibronectin Type III (FN3) polypeptides, which are instrumental in identifying binding peptides with high affinities for VEGFR2 or Axl proteins, specifically those greater than 300 nM. Additionally, he has developed walk-through mutagenesis and natural-variant combinatorial FN3 polypeptide libraries, detailing their construction and application. His research has led to the selection of several high binding affinity polypeptides through screening against various selected antigens.

Career Highlights

Throughout his career, Peter B Kirk has worked with companies such as Protelica, Inc. and Protelix, Inc. His innovative approaches have positioned him as a key figure in the biotechnology sector, contributing to advancements that have practical applications in medicine and research.

Collaborations

Kirk has collaborated with notable professionals in his field, including Guido Cappuccilli and Roberto Crea. These partnerships have further enriched his research and development efforts.

Conclusion

Peter B Kirk's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…